Tushar Srivastava

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Venues

Health technology assessment (Winchester, England)

Clinical drug investigation

PharmacoEconomics

University of Sheffield

Banaras Hindu University (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Sheffield Aug 01 2019

United Kingdom

Researcher - Health Economic Modeller :: School of Health and Related Research (ScHARR)

Complete HEOR Solutions Jun 15 2015 - May 25 2018

United States

Senior Consultant and Team Lead :: Economic Modelling

Education History

Banaras Hindu University Aug 01 2013 - Jun 01 2015

India

MSC :: Institute of Science

University of Delhi Jul 01 2009 - Jun 01 2012

India

BSC :: Mathematics

Publications

Bethan Woods, Laetitia Schmitt, Dina Janković, Benjamin Kearns, Alison Scope, Shijie Ren, Tushar Srivastava, Chu-Chang Ku, Jean Hamilton, Claire Rothery, Laura Bojke, Mark J Sculpher, S E Harnan
Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Health technology assessment (Winchester, England) 28 (28) (2024)
Bethan Woods, Laetitia Schmitt, Dina Janković, Benjamin Kearns, Alison Scope, Shijie Ren, Tushar Srivastava, Chu-Chang Ku, Jean Hamilton, Claire Rothery, Laura Bojke, Mark J Sculpher, S E Harnan
Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Health technology assessment (Winchester, England) 28 (28) (2024)
Bethan Woods, Laetitia Schmitt, Dina Janković, Benjamin Kearns, Alison Scope, Shijie Ren, Tushar Srivastava, Chu-Chang Ku, Jean Hamilton, Claire Rothery, Laura Bojke, Mark J Sculpher, S E Harnan
Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Health technology assessment (Winchester, England) 28 (28) (2024)
Tushar Srivastava, Nicholas R Latimer, Paul Tappenden
Estimation of Transition Probabilities for State-Transition Models: A Review of NICE Appraisals. PharmacoEconomics 39 (8) (2021)
Mohd Masnoon Saiyed, Joshua M Byrnes, Tushar Srivastava, Paul A Scuffham, Martin J Downes
Cost-Effectiveness of Lenvatinib Compared with Sorafenib for the First-Line Treatment of Advanced Hepatocellular Carcinoma in Australia. Clinical drug investigation 40 (12) (2020)

Tushar Srivastava.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tushar Srivastava